Ginkgo Bioworks (NYSE:DNA – Get Free Report) and Eternity Healthcare (OTCMKTS:ETAH – Get Free Report) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, institutional ownership, risk, valuation and dividends.
Insider and Institutional Ownership
78.6% of Ginkgo Bioworks shares are held by institutional investors. 12.7% of Ginkgo Bioworks shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Profitability
This table compares Ginkgo Bioworks and Eternity Healthcare’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Ginkgo Bioworks | -259.96% | -60.27% | -26.88% |
| Eternity Healthcare | N/A | N/A | N/A |
Analyst Ratings
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Ginkgo Bioworks | 2 | 2 | 0 | 0 | 1.50 |
| Eternity Healthcare | 0 | 0 | 0 | 0 | 0.00 |
Ginkgo Bioworks presently has a consensus price target of $7.00, indicating a potential upside of 0.29%. Given Ginkgo Bioworks’ stronger consensus rating and higher possible upside, analysts plainly believe Ginkgo Bioworks is more favorable than Eternity Healthcare.
Earnings & Valuation
This table compares Ginkgo Bioworks and Eternity Healthcare”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Ginkgo Bioworks | $170.15 million | 2.76 | -$312.76 million | ($5.01) | -1.39 |
| Eternity Healthcare | N/A | N/A | N/A | N/A | N/A |
Eternity Healthcare has lower revenue, but higher earnings than Ginkgo Bioworks.
Summary
Ginkgo Bioworks beats Eternity Healthcare on 5 of the 8 factors compared between the two stocks.
About Ginkgo Bioworks
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
About Eternity Healthcare
Eternity Healthcare, Inc. engages in the provision of stem cell storage and related medical therapies in China. Its services include cell derivation and cell banking. The company was founded on October 24, 2007 and is headquartered in Hong Kong.
Receive News & Ratings for Ginkgo Bioworks Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ginkgo Bioworks and related companies with MarketBeat.com's FREE daily email newsletter.
